Synzyme Technology, Inc.

Irvine, CA 92618

SBIR Award Summary

Total Number of Awards 22
Total Value of Awards $6.05MM
First Award Date 03/01/95
Most Recent Award Date 04/01/16

Key Personnel

Last Name Name Awards Contact
Hsia Carleton Hsia 22

22 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-08-235
Budget: 04/01/16 - 03/31/17

DESCRIPTION (provided by applicant): Traumatic brain injury (TBI) is a leading cause of morbidity and mortality especially when complicated by secondary insults such as hypotension. Vulnerability of TBI patients to hypotension is well recognized and identifies a key need for new approaches. The goal of this proposal is to develop to IND a neurop...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-08-235
Budget: 04/01/14 - 03/31/15

DESCRIPTION (provided by applicant): Traumatic brain injury (TBI) is a leading cause of morbidity and mortality especially when complicated by secondary insults such as hypotension. Vulnerability of TBI patients to hypotension is well recognized and identifies a key need for new approaches. The goal of this proposal is to develop to IND a neurop...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-08-235
Budget: 04/01/13 - 03/31/14

DESCRIPTION (provided by applicant): Traumatic brain injury (TBI) is a leading cause of morbidity and mortality especially when complicated by secondary insults such as hypotension. Vulnerability of TBI patients to hypotension is well recognized and identifies a key need for new approaches. The goal of this proposal is to develop to IND a neurop...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-08-235
Budget: 04/01/12 - 03/31/13

DESCRIPTION (provided by applicant): Traumatic brain injury (TBI) is a leading cause of morbidity and mortality especially when complicated by secondary insults such as hypotension. Vulnerability of TBI patients to hypotension is well recognized and identifies a key need for new approaches. The goal of this proposal is to develop to IND a neurop...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PAR-08-235
Budget: 04/01/11 - 03/31/12

DESCRIPTION (provided by applicant): Traumatic brain injury (TBI) is a leading cause of morbidity and mortality especially when complicated by secondary insults such as hypotension. Vulnerability of TBI patients to hypotension is well recognized and identifies a key need for new approaches. The goal of this proposal is to develop to IND a neurop...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/07 - 05/31/09

DESCRIPTION (provided by applicant): Stroke is the 3rd leading cause of death in the U.S. and is also a leading cause of severe, long-term disability. The total cost of stroke to the United States is estimated at about $43 billion per year. The only FDA-approved treatment for acute ischemic stroke is recombinant tissue plasminogen activator (rt...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/06 - 05/31/07

DESCRIPTION (provided by applicant): Stroke is the 3rd leading cause of death in the U.S. and is also a leading cause of severe, long-term disability. The total cost of stroke to the United States is estimated at about $43 billion per year. The only FDA-approved treatment for acute ischemic stroke is recombinant tissue plasminogen activator (rt...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/27/05 - 05/31/06

DESCRIPTION (provided by applicant): Stroke is the 3rd leading cause of death in the U.S. and is also a leading cause of severe, long-term disability. The total cost of stroke to the United States is estimated at about $43 billion per year. The only FDA-approved treatment for acute ischemic stroke is recombinant tissue plasminogen activator (rt...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/15/03 - 03/14/04

DESCRIPTION (provided by applicant): TOPS-ester is a topical drug selected for development for it's unique ability to compartmentalize within skin cells and express antioxidant activity that limits oxidant mediated pathologies including psoriasis, sunburn, skin aging and skin cancer. The objective of this proposal is to use a non-invasive electr...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 07/15/03 - 01/14/04

DESCRIPTION (provided by applicant): The brain damage that frequently accompanies cardiac arrest and resuscitation is devastating. Fewer than 10% of cardiopulmonary resuscitation (CPR) attempts result in survival without brain damage when treatment occurs in pre-hospital or a non-special care hospital environment (Safar, 1993). We propose that ...

Load More